ADRB2, adrenoceptor beta 2, 154

N. diseases: 53; N. variants: 1
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001849
Disease: AIDS Dementia Complex
AIDS Dementia Complex 		0.300 Biomarker disease CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C0019693
Disease: HIV Infections
HIV Infections 		0.300 Biomarker group CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C0206019
Disease: HIV Encephalopathy
HIV Encephalopathy 		0.300 Biomarker disease CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C0243010
Disease: Viral Encephalitis
Viral Encephalitis 		0.300 Biomarker group CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C0936243
Disease: HIV-1-Associated Cognitive Motor Complex
HIV-1-Associated Cognitive Motor Complex 		0.300 Biomarker disease CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C4505456
Disease: HIV Coinfection
HIV Coinfection 		0.300 Biomarker disease CTD_human β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. 27400929 2016
CUI: C0016059
Disease: Fibrosis
Fibrosis 		0.300 Biomarker phenotype CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary 		0.300 Biomarker group CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary 		0.300 Biomarker group CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left 		0.300 Biomarker phenotype CTD_human Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. 25193472 2014
CUI: C0027765
Disease: nervous system disorder
nervous system disorder 		0.300 Biomarker group CTD_human Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. 21245421 2011
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity 		0.300 Biomarker phenotype CTD_human The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker. 19034036 2008
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms 		0.300 Biomarker group CTD_human Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. 17003101 2007
CUI: C1708349
Disease: Hereditary Diffuse Gastric Cancer
Hereditary Diffuse Gastric Cancer 		0.300 Biomarker disease CTD_human Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. 17003101 2007
CUI: C1706412
Disease: Lipidemias
Lipidemias 		0.300 Biomarker phenotype CTD_human beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene. 16027735 2005
CUI: C1449563
Disease: Cardiomyopathy, Familial Idiopathic
Cardiomyopathy, Familial Idiopathic 		0.300 Biomarker disease CTD_human Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. 11986409 2002
CUI: C0040822
Disease: Tremor
Tremor 		0.300 Biomarker phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0040822
Disease: Tremor
Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0040827
Disease: Saturnine Tremor
Saturnine Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0040827
Disease: Saturnine Tremor
Saturnine Tremor 		0.300 Biomarker phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0149840
Disease: Senile Tremor
Senile Tremor 		0.300 Biomarker phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0149840
Disease: Senile Tremor
Senile Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234370
Disease: Persistent Tremor
Persistent Tremor 		0.300 Biomarker phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234370
Disease: Persistent Tremor
Persistent Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997
CUI: C0234371
Disease: Continuous Tremor
Continuous Tremor 		0.300 Therapeutic phenotype CTD_human Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. 9151294 1997